Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sofia Svahn

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Drugs & Aging|November 3, 2024
Differences in Pharmacological Treatment of Heart Failure Among Persons with or without Major Cognitive Disorder: A Cross-Sectional Study Based on National Registries in SwedenLinda Rankin, Sofia Svahn, Jonas Kindstedt, et al.
Exploratory Research in Clinical and Social Pharmacy|April 25, 2025
Geriatric patients' views on a pharmacist-led follow-up programme after discharge from hospitalSofia Svahn, Gisselle Gallego, Maria Gustafsson, et al.
Currents in Pharmacy Teaching & Learning|October 14, 2018
Who enrols and graduates from web-based pharmacy education - Experiences from Northern SwedenSofia Mattsson, Maria Gustafsson, Sofia Svahn, et al.
European Journal of Clinical Pharmacology|January 10, 2020
Cardiovascular drug use among people with cognitive impairment living in nursing homes in northern SwedenSofia Svahn, Hugo Lövheim, Ulf Isaksson, et al.
BMC Geriatrics|August 24, 2024
Prevalence of heart failure and trends in its pharmacological treatment between 2000 and 2017 among very old peopleSofia Svahn, Leona Appelblad, Hugo Lövheim, et al.
BMJ Open|April 30, 2020
Investigating the effect of clinical pharmacist intervention in transitions of care on drug-related hospital readmissions among the elderly: study protocol for a randomised controlled trialJonas Kindstedt, Sofia Svahn, Maria Sjölander, et al.
Journal of Medicinal Chemistry|February 12, 2014
Identification of weak points of hepatitis C virus NS3 protease inhibitors using surface plasmon resonance biosensor-based interaction kinetic analysis and genetic variantsSofia Svahn Gustafsson, Angelica Ehrenberg, Benjamin Schmuck, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|February 13, 2014
Accounting for strain variations and resistance mutations in the characterization of hepatitis C NS3 protease inhibitorsAngelica E Ehrenberg, Benjamin Schmuck, Muhammad Ikram Anwar, et al.
European Journal of Clinical Pharmacology|March 24, 2009
Individualised dosing of amikacin in neonates: a pharmacokinetic/pharmacodynamic analysisCatherine M T Sherwin, Sofia Svahn, Antje Van der Linden, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Drugs & Aging|November 3, 2024
Differences in Pharmacological Treatment of Heart Failure Among Persons with or without Major Cognitive Disorder: A Cross-Sectional Study Based on National Registries in SwedenLinda Rankin, Sofia Svahn, Jonas Kindstedt, et al.
Exploratory Research in Clinical and Social Pharmacy|April 25, 2025
Geriatric patients' views on a pharmacist-led follow-up programme after discharge from hospitalSofia Svahn, Gisselle Gallego, Maria Gustafsson, et al.
Currents in Pharmacy Teaching & Learning|October 14, 2018
Who enrols and graduates from web-based pharmacy education - Experiences from Northern SwedenSofia Mattsson, Maria Gustafsson, Sofia Svahn, et al.
European Journal of Clinical Pharmacology|January 10, 2020
Cardiovascular drug use among people with cognitive impairment living in nursing homes in northern SwedenSofia Svahn, Hugo Lövheim, Ulf Isaksson, et al.
BMC Geriatrics|August 24, 2024
Prevalence of heart failure and trends in its pharmacological treatment between 2000 and 2017 among very old peopleSofia Svahn, Leona Appelblad, Hugo Lövheim, et al.
BMJ Open|April 30, 2020
Investigating the effect of clinical pharmacist intervention in transitions of care on drug-related hospital readmissions among the elderly: study protocol for a randomised controlled trialJonas Kindstedt, Sofia Svahn, Maria Sjölander, et al.
Journal of Medicinal Chemistry|February 12, 2014
Identification of weak points of hepatitis C virus NS3 protease inhibitors using surface plasmon resonance biosensor-based interaction kinetic analysis and genetic variantsSofia Svahn Gustafsson, Angelica Ehrenberg, Benjamin Schmuck, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|February 13, 2014
Accounting for strain variations and resistance mutations in the characterization of hepatitis C NS3 protease inhibitorsAngelica E Ehrenberg, Benjamin Schmuck, Muhammad Ikram Anwar, et al.
European Journal of Clinical Pharmacology|March 24, 2009
Individualised dosing of amikacin in neonates: a pharmacokinetic/pharmacodynamic analysisCatherine M T Sherwin, Sofia Svahn, Antje Van der Linden, et al.
Pageof 1